Ovarian Cancer Clinical Trials in Baltimore

Showing 101-120 of 274 trials

HOT: HIPEC in Ovarian Cancer as Initial Treatment

NCT02124421

Community hospital based phase II (prospective randomized) study to evaluate the toxicity of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in newly diagnosed, otherwise untreated, advanced stage (stage III/IV) epithelial ovarian, fallopian tube, and primary peritoneal cancer.

Stage III Ovarian CancerStage IV Ovarian CancerEpithelial Ovarian Cancer+4 more

Mercy Medical Center32 participantsStarted Apr 2014

Baltimore, Maryland, United States

COMPLETEDPhase 1< 1 mile

Clinical Trial of Combined Fostamatinib and Paclitaxel in Ovarian Cancer

NCT03246074

This research is being done to test the safety of the combination of the study drugs fostamatinib and paclitaxel. This study tests different doses of the drugs to see which doses are safest in people with ovarian cancer when given together.

Ovarian Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins35 participantsStarted Apr 2018

Washington D.C., District of Columbia, United States • Baltimore, Maryland, United States • Philadelphia, Pennsylvania, United States

HOT: HIPEC in Ovarian Cancer as Initial Treatment

Clinical Trial of Combined Fostamatinib and Paclitaxel in Ovarian Cancer

Ovarian Cancer Trials in Other Cities

Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies

A Study to Characterize the Outcomes of Olaparib Maintenance Monotherapy in Newly Diagnosed BRCAwt Ovarian Cancer

SGI-110 in Combination With Carboplatin in Ovarian Cancer

A Study of KB-0742 in Participants With Relapsed or Refractory Solid Tumors Including Platinum Resistant High Grade Serous Ovarian Cancer (HGSOC)

A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies

A Study of XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary Malignancies

p53 Suppressor Activation in Recurrent High Grade Serous Ovarian Cancer, a Phase Ib/II Study of Systemic Carboplatin Combination Chemotherapy With or Without APR-246

Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers

Comprehensive Outcomes for After Cancer Health

A Study of ZN-c3 in Patients With Ovarian Cancer

A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)

A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors

Study of the Safety, Pharmacokinetics and Efficacy of Tinostamustine in Patients With Advanced Solid Tumors.

Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors

A Bioequivalence Study Between the Proposed and Current Talazoparib Capsule Formulation and Food Effect Study for the Proposed Talazoparib Capsule Formulation in Participants With Advanced Solid Tumors

Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors

FPA150 in Patients With Advanced Solid Tumors

Oral AMXT 1501 Dicaprate in Combination With IV DFMO

Other Conditions in Baltimore